CPLD 2005 FFC vs Respondent M04

Facts
The French Cycling Federation (Fédération Française de Cyclisme, FFC) charges respondent M04 for a violation of the Anti-Doping Rules. During a cycling event on May 14, 2004, respondent provided a sample for doping test purposes. Analysis of the sample showed the presence of salbutamol which is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list.

History
The respondent had used medication containing the prohibited substance to treat asthma, she uses this medication over 15 years. There is proof of her condition by test results. The panel concludes that the medication is justifiable.

Decision
1. The respondent is acquitted
2. The decision wil not be published.
3. The decision will be sent to the parties involved.

Original document

CPLD 2005-04 (AS).pdf

Parameters

Legal Source
National Decisions
Date
10 January 2005
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Acquittal
Sport/IFs
Cycling (UCI) - International Cycling Union
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Conseil de Prévention et de Lutte contre le Dopage (CPLD) - Council to Prevent and Counteract Doping
Fédération Française de Cyclisme (FFC) - French Cycling Federation
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S3. Beta-2 Agonists
Substances
Salbutamol
Medical terms
Asthma
Legitimate Medical Treatment
Document type
Pdf file
Date generated
30 October 2014
Date of last modification
31 October 2014
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin